[Top] [All Lists]

[e-drug] BU Systematic Review of "Industry-led Access to Medicines Initiatives in L&MICs

E-DRUG: BU Systematic Review of "Industry-led Access to Medicines Initiatives 
in L&MICs

Health Affairs publication: Boston University's Systematic Review of 
"Industry-led Access to Medicines Initiatives in Low and Middle Income 
Countries: Strategies and Evidence"

Boston University's recent publication in the April edition of Health Affairs 
examines different strategies employed by the pharmaceutical industry in access 
to medicine initiatives in low and middle income countries and explores whether 
rigorous evaluation methods have been utilized to demonstrate impact.

Global biopharmaceutical companies are increasingly establishing 
access-to-medicines (AtM) initiatives in low- and middle-income countries. We 
reviewed the initiatives of twenty-one research-based global biopharmaceutical 
companies to assess their strategies for improving access and the quality of 
evidence on the impact of their initiatives. The number of operating 
initiatives increased from 17 in 2000 to 102 in 2015. 

Of the 120 different AtM initiatives identified, 48 percent used a medicine 
donation strategy, and 44 percent used a price reduction strategy. While 
companies have frequently claimed that their initiatives have had positive 
impacts, we found published evaluations for only seven initiatives, and nearly 
all of the evaluations were of low (62 percent) or very low (32 percent) 

It is clear that the biopharmaceutical industry has increased its commitment to 
improving access to medicines in low- and middle-income countries. However, 
companies should do more to generate high-quality evidence on their 
initiatives, and the global health community should do more to assist the 
developing of evidence about the initiatives.


Erin L. Hasselberg, M.S.

Project Director, Evaluation of Access Accelerated
Program Director, Pharmaceuticals Certificate\
Boston University School of Public Health
Boston, MA 02118  USA
"Hasselberg, Erin" <erinhass@bu.edu>

<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] BU Systematic Review of "Industry-led Access to Medicines Initiatives in L&MICs, Hasselberg, Erin <=